Schedule 13G ownership disclosure
STRUCTURE THERAPEUTICS INC
Common Stock · CUSIP: 86366E106
Event date: 2025-03-31
- Filing-level shares
- 6,492,435.00
- Percent of class
- 3.8%
- Capital Research Global Investors
Shares: 6,492,435.00 · Class: 3.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001422848-25-000060
- Form type
- SCHEDULE 13G/A
- Filer
- Capital Research Global Investors
- CIK
- CIK 1422848
- Filed
- May 13, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership